ZNF384 and acute lymphoblastic leukemia: Among the BCP-ALL “other” patients, DUX4-IGH was detected in eight out of 42 patients and was thus the most common fusion gene in this subgroup, followed by recurrent fusion events involving ZNF384 or PAX5.